elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q62063038-C3F4B25A-0623-4D32-BE08-EACCE4D6822D
Q62063038-C3F4B25A-0623-4D32-BE08-EACCE4D6822D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q62063038-C3F4B25A-0623-4D32-BE08-EACCE4D6822D
Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL
P1476
Q62063038-C3F4B25A-0623-4D32-BE08-EACCE4D6822D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q62063038-C3F4B25A-0623-4D32-BE08-EACCE4D6822D
rank
NormalRank
type
BestRank
Statement
P1476
Phase 1 Trial of Rituximab, Id
......
ymphocytic Leukemia (RIVe-CLL)
@en